BACKGROUND: Dehydroepiandrosterone sulfate (DHEAS) is an endogenously produced sex steroid that has been hypothesized to have anti-aging effects. Low DHEAS levels are associated with mortality in older men, but the relationship between DHEAS levels and mortality in women is not clearly defined. METHODS: The relationship between serum DHEAS level and 5-year mortality was analyzed in a cohort of 539 disabled women aged 65-100 years enrolled in the Women's Health and Aging Study I (WHAS I). Using Cox proportional hazard models, we calculated multivariate-adjusted mortality risks by DHEAS quartiles and by DHEAS continuously, allowing for a nonlinear relationship. We also examined cause-specific mortality. RESULTS: We found a U-shaped relationship between DHEAS level and mortality. After adjusting for multiple covariates, women in the top and bottom DHEAS quartiles had a more than 2-fold higher 5-year mortality than did those in the middle quartiles (hazard ratio, 2.15; 95% confidence interval [CI], 1.17-3.98 for the top quartile and 2.05; 95% CI, 1.27-3.32 for the bottom quartile, each compared to the third quartile). Women with higher DHEAS levels tended to have greater cancer mortality, whereas those with lower DHEAS tended to have greater cardiovascular mortality. CONCLUSION: Disabled older women with either low or high levels of DHEAS are at greater risk for death than are those with intermediate levels. More research is needed to determine if targeted dehydroepiandrosterone supplementation would provide clinical benefit to disabled older women.
BACKGROUND:Dehydroepiandrosterone sulfate (DHEAS) is an endogenously produced sex steroid that has been hypothesized to have anti-aging effects. Low DHEAS levels are associated with mortality in older men, but the relationship between DHEAS levels and mortality in women is not clearly defined. METHODS: The relationship between serum DHEAS level and 5-year mortality was analyzed in a cohort of 539 disabled women aged 65-100 years enrolled in the Women's Health and Aging Study I (WHAS I). Using Cox proportional hazard models, we calculated multivariate-adjusted mortality risks by DHEAS quartiles and by DHEAS continuously, allowing for a nonlinear relationship. We also examined cause-specific mortality. RESULTS: We found a U-shaped relationship between DHEAS level and mortality. After adjusting for multiple covariates, women in the top and bottom DHEAS quartiles had a more than 2-fold higher 5-year mortality than did those in the middle quartiles (hazard ratio, 2.15; 95% confidence interval [CI], 1.17-3.98 for the top quartile and 2.05; 95% CI, 1.27-3.32 for the bottom quartile, each compared to the third quartile). Women with higher DHEAS levels tended to have greater cancer mortality, whereas those with lower DHEAS tended to have greater cardiovascular mortality. CONCLUSION: Disabled older women with either low or high levels of DHEAS are at greater risk for death than are those with intermediate levels. More research is needed to determine if targeted dehydroepiandrosterone supplementation would provide clinical benefit to disabled older women.
Authors: M Maggio; G P Ceda; G De Cicco; E Cattadori; S Visioli; F Ablondi; C Beghi; T Gherli; S Basaria; G Ceresini; G Valenti; L Ferrucci Journal: J Endocrinol Invest Date: 2005-09 Impact factor: 4.256
Authors: Anne B Newman; Jason L Sanders; Jorge R Kizer; Robert M Boudreau; Michelle C Odden; Adina Zeki Al Hazzouri; Alice M Arnold Journal: Int J Epidemiol Date: 2016-06-06 Impact factor: 7.196
Authors: Chrisandra Shufelt; Philip Bretsky; Cristina M Almeida; B Delia Johnson; Leslee J Shaw; Ricardo Azziz; Glenn D Braunstein; Carl J Pepine; Vera Bittner; Diane A Vido; Frank Z Stanczyk; C Noel Bairey Merz Journal: J Clin Endocrinol Metab Date: 2010-08-25 Impact factor: 5.958
Authors: Alden L Gross; Qian-Li Xue; Karen Bandeen-Roche; Linda P Fried; Ravi Varadhan; Mara A McAdams-DeMarco; Jeremy Walston; Michelle C Carlson Journal: J Gerontol A Biol Sci Med Sci Date: 2016-04-15 Impact factor: 6.053
Authors: Marcello Maggio; Fulvio Lauretani; Gian Paolo Ceda; Stefania Bandinelli; Shari M Ling; E Jeffrey Metter; Andrea Artoni; Laura Carassale; Anna Cazzato; Graziano Ceresini; Jack M Guralnik; Shehzad Basaria; Giorgio Valenti; Luigi Ferrucci Journal: Arch Intern Med Date: 2007-11-12
Authors: Anne R Cappola; Ellen S O'Meara; Wensheng Guo; Traci M Bartz; Linda P Fried; Anne B Newman Journal: J Gerontol A Biol Sci Med Sci Date: 2009-08-27 Impact factor: 6.053
Authors: Monik C Jiménez; Qi Sun; Markus Schürks; Stephanie Chiuve; Frank B Hu; Joann E Manson; Kathryn M Rexrode Journal: Stroke Date: 2013-05-23 Impact factor: 7.914